• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Valeo Pharma Appoints President, COO

    Metrion, LifeArc Extend Neuroscience Alliance

    Grifols Begins COVID-19 Plasma Treatment Trial

    Janssen, TenNor Enter NTM Research Pact

    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Cognate BioServices Announces Major Expansion

    Sanofi Unveils EUROAPI as Name of New European API Company

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza

    Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge

    Thermo Fisher Expands Clinical Supply Services in Europe

    Schreiner MediPharm Joins DoseID Consortium
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Metrion, LifeArc Extend Neuroscience Alliance

    Grifols Begins COVID-19 Plasma Treatment Trial

    Janssen, TenNor Enter NTM Research Pact

    Virtual Clinical Trials: The Future of Dermatology Studies

    Cognate BioServices Announces Major Expansion
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management

    CDMO Cognate BioServices Teams Up with L7 Informatics

    The Wasdell Group Earns ISO 13485 Certification
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Emergent BioSolutions

    Adare Pharma Solutions

    Reed-Lane

    Baxter BioPharma Solutions

    Alcami
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    PCI Pharma Services

    Baxter BioPharma Solutions

    Cytovance Biologics

    Alcami

    Flow Sciences
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Back Page

    Biogenerics Progress

    Generic makers target big forays into major markets

    Biogenerics Progress
    Related CONTENT
    • Advancing Digital Endpoints in Clinical Trials
    • Mogene
    • Fujifilm Diosynth to Manufacture Lilly COVID-19 Antibody
    • Vetio Animal Health
    • The Final Frontier
    S. Harachand, Contributing Editor06.12.18
    Competition in the biosimilars market is getting intense as increasing numbers of generic equivalents of biologics gain acceptanace.

    India’s fast-emerging biosimilars industry received a boost due to a new set of regulatory guidelines coming into force that are designed to ensure quality, efficacy and safety of biosimilars. The new regulations have also set the pace for the approval process of biologic products.

    India issued guidelines for ‘similar biologics’ in 2016. Companies soon started launching low-priced versions of top-selling biotherapeutics, one after the other, leaving room for the market to expand further.

    In January, Mumbai-based Glenmark Pharma introduced adalimumab, a biosimilar to AbbVie’s Humira. Sales of the rheumatoid arthritis treatment were $18.4 billion in 2017 and are estimated to grow to $21 billion by 2021. The TNF inhibitor is being prescribed for other auto immune disorders like plaque psoriasis.

    In the same month, Hetero Drugs of Hyderabad also launched a biosimilar to adalimumab. A leader in antiretrovirals, the south Indian firm has already commercialized biosimilars to darbepoetin alfa, rituximab and bevacizumab. 

    Earlier, Zydus Cadila of Ahmedabad came out with adalimumab, which is currently sold under the brand name Exemptia. Glenmark brought the drug to market under a licensing agreement with Cadila Healthcare. Glenmark and Hetero are relatively new entrants into the biosimilars scene.

    Recently, Biocon, a pioneer in India’s biotherapeutics industry, secured approval for trastuzumab from the U.S. Food and Drug Administration (FDA). Biocon’s is the first biosimilar of Roche’s breast cancer drug Herceptin approved by FDA. Already listed among the World Health Organization’s (WHO) essential medicines, trastuzumab biosimilar presents a $6 billion global opportunity, reports estimate. Biocon partnered with Mylan for the development of the drug. The Bengaluru-based company’s R&D pipeline is rich with biosimilars including pegfilgrastim, insulin glargine and bevacizumab. It is looking at winning more approvals for the U.S. and EU markets.

    Similarly, Sun Pharma received clearance from FDA for tildrakizumab for the treatment of plaque psoriasis. The Mumbai-based company licensed worldwide rights to tildrakizumab from Merck & Co. in 2014 and subsequently funded the Phase III trial of  the biologic. Sun Phrama will take full control of the product post approval. Tildrakizumab, which targets interleukin-23 (IL-23), will now compete with Janssen’s guselkumab as well as the other IL-17 therapeutics approved for the indication so far, such as ustekinumab (J&J), secukinumab (Novartis) and ixekizumab (Eli Lilly) in the psoriasis market in the U.S. IL-23 inhibitor biologics have an edge over IL-17 blockers as the former require fewer injections.

    Lupin announced in May that the company submitted a new drug approval (NDA) for a biosimilar of etanercept in Japan through Yoshindo, its joint venture partner. Etanercept is the first biosimilar developed as part of the tie-up. Japan’s biologics market is estimated to reach $13.5 billion in 2019, according to the Lupin release. Lupin is planning to build the company’s biosimilars pipeline and expects to file for etanercept approval in the U.S. and Europe in the next couple of years.

    As Indian companies tighten their grip on highly successful biologic products, industry experts are saying that the country’s biotherapeutics manufacturing sector is steadily maturing.

    The companies enjoy a development and manufacturing advantage by working on the drugs in India. Biosimilars are starting to track the dynamics of small molecule products. The uptake of biosimilars globally will continue to grow as payers and governments look for more affordable drugs with assured quality. Players with unmatched quality standards and technical prowess stand to gain.

    In addition, efforts are underway globally to harmonize regulatory guidelines. A dossier common for use both in the U.S. and European markets is currently under discussion. According to a recent CPhI report, “The dynamics of the biosimilar market are shifting towards congruence with the generics and adoption should now accelerate.”

    But the hitch is, unlike small molecules, the making of biosimilars demands a much larger investment. Biosimilars require extensive clinical development and can cost upwards of $150 million. More than 80% of the total cost goes into clinical development of the molecule, whereas a chemical generic might cost only $1 to $5 million as it only requires BA/BE studies, analysts pointed out.

    Notwithstanding the high costs, a handful of Indian companies are making huge bets investing in R&D and vying for a piece of the biosimilars pie that is estimated to be worth between $25 billion and $35 billion by 2020. 


    S. Harachand
    Contributing Editor

    S. Harachand is a pharmaceutical journalist based in Mumbai. He can be reached at harachand@gmail.com.
    Related Searches
    • it
    • clinical development
    • Development
    • generics
    Suggested For You
    Advancing Digital Endpoints in Clinical Trials Advancing Digital Endpoints in Clinical Trials
    Mogene Mogene
    Fujifilm Diosynth to Manufacture Lilly COVID-19 Antibody Fujifilm Diosynth to Manufacture Lilly COVID-19 Antibody
    Vetio Animal Health Vetio Animal Health
    The Final Frontier The Final Frontier
    DCAT Sharp Sourcing 2018 DCAT Sharp Sourcing 2018
    Legacy Completes Executive Team Legacy Completes Executive Team
    Lilly Lilly's Taltz Gains Label Update
    The Beginning of a New Era? The Beginning of a New Era?
    Lilly Hires Immuno-Oncology Lead Lilly Hires Immuno-Oncology Lead
    Changing Dynamics: The CDMO market in focus Changing Dynamics: The CDMO market in focus
    Lilly, Sigilon Partner for Diabetes Lilly, Sigilon Partner for Diabetes
    Mylan, Biocon Receive MAA Mylan, Biocon Receive MAA
    APC Expands Executive Team APC Expands Executive Team
    Immutep, Merck & Co. Enter Partnership Immutep, Merck & Co. Enter Partnership

    Related Back Page

    • Biologics, Proteins, Vaccines | Biosimilars | R&D
      The Global Biotech Boom

      The Global Biotech Boom

      How an industry grew to lead health care innovation and how CROs are adapting to meet their needs.
      Davide Garrisi, PPD Biotech 09.09.20

    • Biologics, Proteins, Vaccines | Biosimilars
      Biotech Booms in the Yangtze River Valley

      Biotech Booms in the Yangtze River Valley

      A look at forces shaping the course of biotech growth in China
      Daniel Burch, M.D., Global Medical Officer, PPD Biotech 05.07.19

    • Biologics, Proteins, Vaccines | Clinical Trials
      Getting to First-in-Human Clinical Trials

      Getting to First-in-Human Clinical Trials

      A make-or-break milestone for small biopharmas
      David Kenyon, Patheon 10.10.18


    • Analytical Services | Biosimilars

      How to Build Better Proteins

      Advancing the next generation of biologics
      Aileen Ruff, Catalent 03.09.16

    • Biosimilars | Validation

      Biosimilars on the Horizon

      The emerging biosimilar market is ripe with opportunities for CROs and CMOs to imprint their brand
      Cliff Echols, Bluebox Research 10.07.15

    • Biosimilars

      Biopharma Nomenclature

      Citizen petition requests biopharmaceutical names and information be disclosed by FDA
      Ronald A. Rader, Biotechnology Information Institute 09.05.13


    Trending
    • Fujifilm To Invest $2B In US Manufacturing Site
    • Roche Canada To Invest $500M To Create 500 Jobs In Ontario
    • Tonix And Fujifilm Enter COVID-19 Vax Deal
    • Virtual Clinical Trials: The Future Of Dermatology Studies
    • Sanofi Unveils EUROAPI As Name Of New European API Company
    Breaking News
    • Valeo Pharma Appoints President, COO
    • Metrion, LifeArc Extend Neuroscience Alliance
    • Grifols Begins COVID-19 Plasma Treatment Trial
    • Janssen, TenNor Enter NTM Research Pact
    • KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Maternal Dietary Intake of Fish, Omega-3s, and Omega-6s Linked to Child Neurodevelopment
    Short Term Low-Carb Diet Linked to Remission of Type 2 Diabetes
    Brown Fat Associated with Reductions in Chronic Disease Risk
    Coatings World

    Latest Breaking News From Coatings World

    Huntsman Finalizes Acquisition of Gabriel Performance Products
    PPG Completes COLORFUL COMMUNITIES Project at School in A. Bangsaothong Samutprakarn, Thailand
    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FineHeart Successfully Tests Wireless TET System
    Apria Healthcare Settles Whistleblower Lawsuit
    OraSure’s OMNIgene·ORAL Device Included in COVID-19 EUA Amendment
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Valeo Pharma Appoints President, COO
    Metrion, LifeArc Extend Neuroscience Alliance
    Grifols Begins COVID-19 Plasma Treatment Trial
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    JLo Beauty Launches at Sephora & Amazon
    Unilever and Alibaba Group Join Forces
    Redken Unveils Acidic Bonding Concentrate Range
    Happi

    Latest Breaking News From Happi

    A Surge in Interest for Supplements & Vitamins
    Manscaped Expands Further in Europe
    Color Street Gives Back
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Ontex Honored for Mask Production
    TFP Acquires PV3 Technologies
    Shemesh Adds U.S. Headquarters
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    OrthoPediatrics Expands Agent Network in Three European Countries
    Studies Show FlareHawk Expandable Cage Delivers Favorable Fusion, Patient Outcomes
    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login